wright–giemsa composite staining kit kge1107 (Keygen Biotech)
90
Structured Review
Keygen Biotech
wright–giemsa composite staining kit kge1107
Wright–Giemsa Composite Staining Kit Kge1107, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wright%E2%80%93giemsa+composite+staining+kit+kge1107/wright+giemsa+composite+staining+kit+kge1107/pm40053279-67-16-21
Average 90 stars, based on 1 article reviews
Wright–Giemsa Composite Staining Kit Kge1107, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wright%E2%80%93giemsa+composite+staining+kit+kge1107/wright+giemsa+composite+staining+kit+kge1107/pm40053279-67-16-21
Average 90 stars, based on 1 article reviews
wright–giemsa composite staining kit kge1107 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Replication factor C4, which is regulated by insulin-like growth factor 2 mRNA binding protein 2, enhances the radioresistance of breast cancer by promoting the stemness of tumor cells. Article Snippet: Radiotherapy resistance, is usually caused by enhanced tumor stemness and poses a significant challenge in treating breast cancer (BRCA).. In this study, we investigated the molecular regulatory mechanism of radiotherapy sensitivity in BRCA associated with replication factor C4 (RFC4) and insulin-like growth factor 2 mRNA binding protein 2 mRNA Binding Protein 2 (IGF2BP2).. RFC4 expression was increased in BRCA cell lines and tissues, and high RFC4 expression in BRCA patients predicted the occurrence of lymphatic metastasis. |